| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |